IMLYGIC is a genetically modified herpes simplex virus type 1; A replication selective in tumor cells; Inducing GM‐CSF and antitumor immune response; Ruptures tumors and then releases tumor‐derived antigens; Cell lysis. The gene discussed is CSF2; the disease is neoplasm.